A few weeks ago researchers at Oxford University announced promising results from early trials of their version of a COVID-19 vaccine. In early trial results on just over 1,000 volunteers, the vaccine appeared to be safe and triggered an immune response. VOA spoke with one volunteer who is participated in phase two trials. VOA’s Dino Jahic reports.
